Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

INTRODUCTION: Effective treatment of reactive arthritis would ideally achieve both control of inflammation and eradication of persisting arthritogenic pathogens. We use a model of experimental Chlamydia trachomatis-induced arthritis (CtIA) to evaluate the effectiveness of nafamostat mesilate (NM), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Inman, Robert D, Chiu, Basil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446536/
https://www.ncbi.nlm.nih.gov/pubmed/22716645
http://dx.doi.org/10.1186/ar3886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446536/
https://www.ncbi.nlm.nih.gov/pubmed/22716645
http://dx.doi.org/10.1186/ar3886

Ejemplares similares